Robert E. Wanerman, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Bloomberg BNA Health Care Daily Report, in “Program to Speed Medical Device Coverage Now Permanent,” by Michael D. Williamson. (Read the full version – subscription required).
Following is an excerpt:
Acquiring Medicare coverage for a new medical device is crucial to a product’s success, especially as many private payers partially base their own coverage determinations on what the CMS decides.
Reacting to the notice, health-care and life sciences attorney Robert Wanerman told Bloomberg BNA Oct. 21 the extended program is too narrow and changes are needed. Wanerman is an attorney with Epstein Becker & Green PC in Washington.